FDA Clearance Tracker · P040043-S037
GORE TAG THORACIC ENDOPROSTESIS
Last checked: Nov 20, 2026Latest source record: Feb 24, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Feb 24, 2011
Approved
Time to decision
175 days
Received Sep 2, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040043-S037
- Device name
- GORE TAG THORACIC ENDOPROSTESIS
- Applicant
- W. L. Gore & Associates, Inc.
- Applicant location
- Flagstaff, AZ
- Received
- Sep 2, 2010
- Decided
- Feb 24, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P040043
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL TO UPDATE THE GORE TAG THORACIC ENDOPROSTHESIS INSTRUCTIONS FOR USE TO INCLUDE SUMMARY INFORMATION ON THE EVALUATION OF THE PHYSICIAN TRAINING PROGRAM FOR THIS DEVICE.
Source documents
Other decisions for W. L. Gore & Associates, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- GORE® VIABAHN® VBX Balloon Expandable EndoprosthesisPMA supplement
P160021-S051 · Decided Oct 8, 2026 · 244 days after receipt · Panel Track
Device type: Iliac covered stent, arterial (PRL) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.